Jeffrey Holyoke is the Vice President, Quality at Neurotech joining in September of 2020. Prior to that, he served in positions of increasing responsibility and was the Global Quality Senior Director/Site Head for Takeda Pharmaceuticals Vaccines Business Unit overseeing Quality Operations for the Cambridge and Singapore sites. While at Takeda, Jeff also served as the U.S. Regional Head for the Global Quality Audit Team, as well site remediation, regulatory pre-approval authorization inspection readiness and inspection support capacity as well as the a technical quality auditor specializing in aseptic processes.
Over the course of his 30 year career, Jeff has served in all areas of Quality, CMC and Manufacturing for Biotech companies such as Biogen, Sunovion (formerly Sepracor, a subsidiary of Sumitomo Dainippon Pharma), and in application chemist/methods development for companies such as Associates of Cape Cod (Manufacturer of the LAL bacterial Endotoxin kit) and Waters Corporation as an Bio-application/LC/MS chemist. Additionally, Jeff has implemented GMP testing facilities for companies such as Springborn Smithers.
Jeff is a Certified Quality Auditor both in the U.S. (ASQ CQA) and internationally (IRCA). Jeffs background is in both in Microbiology and Human (analytical) Biochemistry. Jeff served as a medic in the United States Air Force while attending Black Hills State University and was honorably discharged in 1987. Jeff received his B.S. from University of New Hampshire in 1991.